Related Experiment Videos
A clinician's guide to Pap smear interpretation
1Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Ga., USA.
The Nurse Practitioner
|April 1, 1997
Summary
Early detection of cervical cancer through Papanicolaou (Pap) smear screening significantly improves cure rates. This review covers risk factors, diagnosis, classification systems, and future screening techniques for cervical disease.
Area of Science:
- Oncology
- Gynecologic Pathology
- Public Health
Background:
- Cervical cancer is a leading cause of cancer death globally and in the US.
- In 1995, the US recorded 15,800 invasive cervical cancer cases and 4,800 deaths.
- The Papanicolaou (Pap) smear has been crucial in identifying preinvasive cervical disease.
Purpose of the Study:
- To provide a comprehensive overview of cervical cancer.
- To discuss risk factors, diagnostic essentials, and treatment guidelines.
- To compare Pap smear classification systems and explore future screening techniques.
Main Methods:
- Literature review of cervical cancer epidemiology, diagnosis, and management.
- Analysis of Pap smear classification systems.
- Discussion of current and emerging screening technologies.
Main Results:
- Early diagnosis via Pap smear leads to >95% cure rates for cervical disease.
- Understanding risk factors is key to prevention and early detection.
- Standardized classification and updated screening protocols enhance patient outcomes.
Conclusions:
- The Pap smear is a highly effective tool for cervical cancer screening.
- Continued research into risk factors and screening techniques is vital.
- Multifaceted approaches including screening, diagnosis, and treatment are essential for combating cervical cancer.